Black Rock Inc. 4 D Molecular Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,284,548 shares of FDMT stock, worth $94.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,284,548

Previous 3,464,587 23.67%

Holding current value

$94.3 Million

Previous $70.2 Million 94.47%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.03 - $35.87 $14 Million - $29.4 Million	819,961 Added 23.67%	4,284,548 $137 Million
Q4 2023 Feb 13, 2024	BUY	$9.76 - $21.25 $3.33 Million - $7.24 Million	340,911 Added 10.91%	3,464,587 $70.2 Million
Q3 2023 Nov 13, 2023	BUY	$12.64 - $19.76 $2.64 Million - $4.13 Million	209,246 Added 7.18%	3,123,676 $39.8 Million
Q2 2023 Aug 11, 2023	BUY	$15.16 - $23.26 $5.51 Million - $8.46 Million	363,695 Added 14.26%	2,914,430 $52.7 Million
Q1 2023 May 12, 2023	BUY	$15.45 - $23.19 $650,491 - $976,368	42,103 Added 1.68%	2,550,735 $43.8 Million

Q4 2022 Feb 13, 2023	BUY	$6.85 - $25.46 $1.91 Million - $7.08 Million	278,233 Added 12.47%	2,508,632 $55.7 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $331,581 - $546,918	47,641 Added 2.18%	2,230,399 $17.9 Million
Q2 2022 Aug 12, 2022	BUY	$5.68 - $15.99 $298,381 - $839,986	52,532 Added 2.47%	2,182,758 $15.2 Million
Q1 2022 May 12, 2022	BUY	$13.16 - $22.64 $559,879 - $963,196	42,544 Added 2.04%	2,130,226 $32.2 Million
Q4 2021 Feb 10, 2022	BUY	$19.56 - $32.94 $12.7 Million - $21.4 Million	649,319 Added 45.14%	2,087,682 $45.8 Million
Q3 2021 Nov 09, 2021	BUY	$22.73 - $36.04 $16.1 Million - $25.5 Million	706,953 Added 96.66%	1,438,363 $38.8 Million
Q2 2021 Aug 11, 2021	BUY	$22.2 - $42.29 $16.2 Million - $30.9 Million	731,410 New	731,410 $17.6 Million

Others Institutions Holding FDMT

# of Institutions

157

Shares Held

50.3M

Call Options Held

718K

Put Options Held

370K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $712M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account